145 related articles for article (PubMed ID: 20025554)
21. Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus.
Yoshihara T; Kumashiro N; Kanazawa Y; Mita T; Sakurai Y; Kawai J; Abe M; Motojima K; Hara K; Yamazaki Y; Kanazawa A; Miwa S; Sato F; Kanno R; Shimizu T; Sakai K; Uchino H; Watada H; Tanaka Y; Kawamori R; Hirose T
Endocr J; 2006 Feb; 53(1):67-72. PubMed ID: 16543674
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of pioglitazone on type 2 diabetic patients with hemodialysis.
Abe M; Kikuchi F; Okada K; Kaizu K; Matsumoto K
Diabetes Res Clin Pract; 2008 Jun; 80(3):432-8. PubMed ID: 18346811
[TBL] [Abstract][Full Text] [Related]
23. Clinical investigation of the effects of pioglitazone on the improvement of insulin resistance and blood pressure in type 2-diabetic patients undergoing hemodialysis.
Abe M; Okada K; Kikuchi F; Matsumoto K
Clin Nephrol; 2008 Sep; 70(3):220-8. PubMed ID: 18793563
[TBL] [Abstract][Full Text] [Related]
24. Comparison Between Effectiveness of 100 mg/day Sitagliptin and a Switch to Mitiglinide Calcium Hydrate/Voglibose from 50 mg/day Sitagliptin in Patients with Type 2 Diabetes.
Arao T; Okada Y; Torimoto K; Sugai K; Otsuka T; Kurozumi A; Tanaka Y
J UOEH; 2017; 39(1):1-9. PubMed ID: 28331117
[TBL] [Abstract][Full Text] [Related]
25. Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus.
Ihana-Sugiyama N; Yamamoto-Honda R; Sugiyama T; Tsujimoto T; Kakei M; Noda M
Med Sci Monit Basic Res; 2017 Feb; 23():36-44. PubMed ID: 28242866
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of type 2 diabetic patients responding to voglibose administration as an adjunct to sulfonylurea.
Hirose T; Miyashita Y; Takagi M; Sumitani S; Kouhara H; Kasayama S
Diabetes Res Clin Pract; 2001 Oct; 54(1):9-15. PubMed ID: 11532325
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naïve Japanese patients with type 2 diabetes.
Ohta A; Ohshige T; Sakai K; Nakamura Y; Tenjin A; Tsukiyama S; Terashima Y; Matsubara F; Kawata T; Nagai Y; Tanaka Y
Expert Opin Pharmacother; 2013 Dec; 14(17):2315-22. PubMed ID: 24079645
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of mitiglinide and sitagliptin, alone or in combination, on postprandial excursion and glycemic variability assessed by continuous glucose monitoring: a post hoc analysis with single-day treatment.
Baek JH; Jin SM; Kaku K; Jung JA; Kim JR; Ko JW; Kim MJ; Lee SY; Huh WS; Kim JH
Expert Opin Pharmacother; 2015 Jun; 16(8):1127-36. PubMed ID: 25881690
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Glycemic Excursion Using Flash Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Before and After Treatment with Voglibose.
Kasthuri S; Poongothai S; Anjana RM; Selvakumar J; Muthukumar S; Kayalvizhi S; Tariq S; Honey E; Gupta PK; Venkatesan U; Mohan V
Diabetes Technol Ther; 2021 Mar; 23(3):213-220. PubMed ID: 32916063
[No Abstract] [Full Text] [Related]
30. Comparison of efficacy of concomitant administration of mitiglinide with voglibose and double dose of mitiglinide in patients with type 2 diabetes mellitus.
Katsuno T; Watanabe N; Nagai E; Okazaki K; Yokoyama A; Hamaguchi T; Miyagawa J; Namba M
J Diabetes Investig; 2011 Jun; 2(3):204-9. PubMed ID: 24843485
[TBL] [Abstract][Full Text] [Related]
31. Comparing postprandial efficacy in type 2 diabetic patients receiving mitiglinide and sitagliptin by using continuous glucose monitoring: a pilot study.
Ando K; Nishimura R; Seo C; Tsujino D; Sakamoto M; Utsunomiya K
Expert Opin Pharmacother; 2014 Dec; 15(17):2479-85. PubMed ID: 25327311
[TBL] [Abstract][Full Text] [Related]
32. Mitiglinide: a rapid- and short-acting non-sulfonylurea insulinotropic agent for the treatment of type 2 diabetic patients.
Malaisse WJ
Expert Opin Pharmacother; 2008 Oct; 9(15):2691-8. PubMed ID: 18803455
[TBL] [Abstract][Full Text] [Related]
33. Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide.
Kitasato L; Tojo T; Hatakeyama Y; Kameda R; Hashikata T; Yamaoka-Tojo M
Cardiovasc Diabetol; 2012 Jun; 11():79. PubMed ID: 22748110
[TBL] [Abstract][Full Text] [Related]
34. Mitiglinide for type 2 diabetes treatment.
Phillippe HM; Wargo KA
Expert Opin Pharmacother; 2013 Oct; 14(15):2133-44. PubMed ID: 23992284
[TBL] [Abstract][Full Text] [Related]
35. The dipeptidyl peptidase-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis.
Fujii Y; Abe M; Higuchi T; Mizuno M; Suzuki H; Matsumoto S; Ito M; Maruyama N; Okada K; Soma M
Expert Opin Pharmacother; 2013 Feb; 14(3):259-67. PubMed ID: 23289982
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of voglibose in comparison with acarbose in type 2 diabetic patients.
Vichayanrat A; Ploybutr S; Tunlakit M; Watanakejorn P
Diabetes Res Clin Pract; 2002 Feb; 55(2):99-103. PubMed ID: 11796175
[TBL] [Abstract][Full Text] [Related]
37. Long-term Effects of Mitiglinide in Japanese Diabetics Inadequately Controlled with DPP-4 Inhibitor or Biguanide Monotherapy.
Kaku K; Inagaki N; Kobayashi N
Diabetes Ther; 2014 Jun; 5(1):97-111. PubMed ID: 24488695
[TBL] [Abstract][Full Text] [Related]
38. Pleiotropic effects of mitiglinide in type 2 diabetes mellitus.
Konya H; Miuchi M; Konishi K; Nagai E; Ueyama T; Kusunoki Y; Kimura Y; Nakamura Y; Ishikawa T; Inokuchi C; Katsuno T; Hamaguchi T; Miyagawa J; Namba M
J Int Med Res; 2009; 37(6):1904-12. PubMed ID: 20146890
[TBL] [Abstract][Full Text] [Related]
39. Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis.
Mirani M; Berra C; Finazzi S; Calvetta A; Radaelli MG; Favareto F; Graziani G; Badalamenti S
Diabetes Technol Ther; 2010 Oct; 12(10):749-53. PubMed ID: 20809678
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of adding once- and thrice-daily voglibose in Japanese type 2 diabetic patients treated with alogliptin.
Takahara M; Shiraiwa T; Katakami N; Kaneto H; Matsuoka TA; Shimomura I
Endocr J; 2014; 61(5):447-56. PubMed ID: 24561488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
